User: Guest  Login
Document type:
Meeting Abstract
Author(s):
Retz, M; Bedke, J; Herrmann, E; Grimm, MO; Zimmermann, U; Müller, L; Leiber, C; Teber, D; Wirth, M; Bolenz, C; van Alphen, R; De Santis, M; Beeker, A; Frank, M; Gschwend, JE
Title:
Phase III randomized, sequential, open-label study to evaluate the efficacy and safety of sorafenib-pazopanib versus pazopanib-sorafenib in the treatment of metastatic renal cell carcinoma (SWITCH-II)
Journal title abbreviation:
Ann Oncol
Year:
2017
Journal volume:
28 5
Pages contribution:
-
Language:
eng
Print-ISSN:
0923-7534
TUM Institution:
Urologische Klinik und Poliklinik
 BibTeX